Prognostic relevance of AgNORs in tumor pathology

Micron

Volumn 31, Issue 2, 2000, Pages 133-141

  Pich, A ^a   Chiusa, L ^a   Margaria, E ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Prognosis; Proliferation; Prospective study; Review; Risk groups; Silver stained nucleolar organizer regions (AgNORs); Tumor

Indexed keywords

NUCLEAR PROTEIN;

ADULT; ARTICLE; CHEMISTRY; CHROMOSOME NOR; FEMALE; HUMAN; MALE; NEOPLASM; PROGNOSIS; SILVER STAINING; ULTRASTRUCTURE;

ADULT; FEMALE; HUMANS; MALE; NEOPLASMS; NUCLEAR PROTEINS; NUCLEOLUS ORGANIZER REGION; PROGNOSIS; SILVER STAINING;

EID: 0034174682     PISSN: 09684328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-4328(99)00070-0     Document Type: Article

References (69)

1. Aaltomaa S., Lipponen P., Syrjanen K. Nucleolar organizer regions related to morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis in female breast cancer. Pathol. Res. Pract. 189:1993;416-421.
2. Abe K., Masai M., Isaka S., Shimazaki J., Matsuzaki O. Nucleolar organizer regions in renal cell carcinoma. Nippon Hinyokika Gakkai Zasshi. 84:1993;642-649.
3. Anonymous. NORs - a new method for the pathologist. Lancet. 1:1987;1413-1414.
4. Bostock D.E., Crocker J., Harris K., Smith P. Nucleolar organiser regions as indicators of post-surgical prognosis in canine spontaneous mast cell tumours. Br. J. Cancer. 59:1989;915-918.
5. Chiusa L., Formiconi A., Galliano D., Di Primio O., Pich A. AgNORs, nuclear and nucleolar morphometry in prostate carcinoma. Eur. J. Histochem. 40:1996;337.
6. Chiusa L., Galliano D., Formiconi A., Di Primio O., Pich A. High and low risk prostate carcinoma determined by histologic grade and proliferative activity. Cancer. 79:1997;1956-1963.
7. Cohen R.J., Glezerson G., Haffejee Z., Afrika D. Prostatic carcinoma: histological and immunohistological factors affecting prognosis. Br. J. Urol. 66:1990;405-410.
8. Cox D.R. Regression models and life tables. J. R. Stat. (Series B). 34:1972;187-220. with discussion.
9. Crocker J., Nar P. Nucleolar organizer regions in lymphomas. J. Pathol. 151:1987;111-118.
10. Crocker J., Skilbeck N. Nucleolar organizer regions in melanocytic lesions: a quantitative study. J. Clin. Pathol. 40:1987;885-889.
11. Crocker J., Macartney J.C., Smith P.J. Correlation between DNA flow cytometry and nucleolar organizer regions in non-Hodgkin's lymphoma. J. Pathol. 154:1988;151-156.
12. Crocker J., Boldy D.A.R., Egan M.J. How should we count AgNORs? Proposals for a standardized approach. J. Pathol. 158:1989;185-188.
13. DeCapoa A., Baldini A., Markelaj P., Natoli C., Rocchi M., Archidiacono N., Ciaufarani S., Spadoni G.L., Boscherini B. Hormone-regulated rRNA gene activity is visualized by selective staining of the NORs. Cell. Biol. Int. Rep. 9:1985;791-796.
14. Derenzini M., Pession A., Trerè D. Quantity of nucleolar silver-stained proteins is related to proliferative activity in cancer cells. Lab. Invest. 63:1990;137-140.
15. Derenzini M., Ploton D. Interphase nucleolar organizer regions in cancer cells. Richter G.W., Solez K., International Review of Experimental Pathology: Molecular Cell Pathology. 1991;149-192 Academic Press, New York.
16. Derenzini M., Trerè D. Importance of interphase nucleolar organizer regions in tumor pathology. Virchows Arch. B Cell. Pathol. 61:1991;1-8.
17. Derenzini M., Sirri V., Trerè D. Nucleolar organizer regions in tumor cells. Cancer J. 7:1994;71-77.
18. Derenzini M., Sirri V., Trerè D., Ochs R.L. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells. Lab. Invest. 73:1995;497-502.
19. Dong H., Bertler C., Schneider E., Ritter M.A. Assessment of cell proliferation by AgNOR scores and Ki-67 labeling indices and a comparison with potential doubling times. Cytometry. 28:1997;280-288.
20. Egan M.J., Raafat F., Crocker J., Williams D. Comparative study of the degree of differentiation of neuroblastoma and mean numbers of nucleolar organiser regions. J. Clin. Pathol. 41:1988;527-531.
21. Egan M.J., Crocker J. Nucleolar organizer regions in pathology. Br. J. Cancer. 65:1992;1-7.
22. Figarella-Branger D., Gambarelli D., Dollo C., Devictor B., Perez-Castillo A.M., Genitori L., Lena G., Choux M., Pellissier J.F. Infratentorial ependymomas of childhood. Correlation between histological features, immunohistological phenotype, silver nucleolar organizer region staining values and post-operative survival in 16 cases. Acta Neuropathol. 82:1991;208-216.
23. Fonseca I., Soares J. Adenoid cystic carcinoma: a study of nucleolar organizer regions (AgNOR) counts and their relation to prognosis. J. Pathol. 169:1993;255-258.
24. Giri D.D., Nottingham J.F., Lawry J., Dundas S.A.C., Underwood J.C.E. Silver-binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions. Correlation with ploidy and growth phase by DNA flow cytometry. J. Pathol. 157:1989;307-313.
25. Griffiths A.P., Cross D., Kingston R.E., Harkin P., Wells M., Quirke P. Flow cytometry and AgNORs in benign, borderline, and malignant mucinous and serous tumours of the ovary. Int. J. Gynecol. Pathol. 12:1993;307-314.
26. Hall P.A., Crocker J., Watts A., Stansfeld A.G. A comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin's lymphoma. Histopathology. 12:1988;373-381.
27. Howat A.J., Giri D.D., Wright A.L., Underwood J.C.E. Silver-stained nucleoli and nucleolar organizer region counts are of no prognostic value in thick cutaneous malignant melanoma. J. Pathol. 156:1988;227-232.
28. Kajiwara K., Nishizaki T., Orita T., Nakayama H., Aoki H., Ito H. Silver colloid staining technique for analysis of glioma malignancy. J. Neurosurg. 73:1990;113-117.
29. Kuratsu S., Tomita Y., Myoui A., Uchida A., Ono K., Aozasa K. DNA ploidy pattern and cell cycle stage of tumor cells in soft-tissue sarcomas: clinical implications. Oncology. 52:1995;363-370.
30. Leek R.D., Alison M.R., Sarraf C.E. Variations in the occurence of silver-staining nucleolar organizer regions (AgNORs) in non-proliferating and proliferating tissues. J. Pathol. 165:1991;43-51.
31. Lipponen P.K., Eskelinen M.J., Nordling S. Nucleolar organiser regions (AgNORs) as predictors in transitional cell bladder cancer. Br. J. Cancer. 64:1991;1139-1144.
32. Marmont F., Pich A., Chiusa L., Locatelli F., Falda M., Boccadoro M., Resegotti L. Correlation between argyrophilic nucleolar organizer region counts and labelling index in multiple myeloma. Eur. J. Haematol. 56:1996;39-44.
33. Miyazaki S., Sasano H., Suzuki T., Sawai T., Nishihira T., Mori S. Nucleolar organizer regions in human esophageal disorders: comparison with proliferating cell nuclear antigen by immunostaining. Modern Pathol. 5:1992;396-401.
34. Moran K., Cooke T., Foster G., Gillen P., Sheehan S., Dervan P., Fitzpatrick J.M. Prognostic value of nucleolar organizer regions and ploidy values in advanced colorectal cancer. Br. J. Surg. 76:1989;1152-1155.
35. Mourad W.A., Connelly J.H., Sembera D.L., Neely Atkinson E., Bruner J.M. The correlation of two argyrophilic nucleolar organizer region counting methods with bromodeoxyuridine-labeling index. Human Pathol. 24:1993;206-210.
36. Nagatani T., Iemoto G., Miyakawa K., Ichiyama S., Takahashi Y., Uchiyama M., Nakajima H. AgNOR (nucleolar organizer regions) staining in malignant melanoma. J. Dermatol. 18:1991;731-735.
37. Nairn E.R., Crocker J., Mc Govern J. Limited value of AgNOR enumeration in the assessment of thyroid neoplasm. J. Clin. Pathol. 41:1988;1136.
38. Nicoll J.A., Candy E. Nucleolar organizer regions and post-operative survival in glioblastoma multiforme. Neuropathol. Appl. Neurobiol. 17:1991;17-20.
39. Öfner D., Tötsch M., Sandbichler P., Hallbrucker C.H.R., Margreiter R., Mikuz G., Schmid K.W. Silver stained nucleolar organizer region proteins (AgNORs) as a predictor of prognosis in colonic cancer. J. Pathol. 162:1990;43-49.
40. Öfner D., Aubele M., Biesterfeld S., Derenzini M., Gimenez-Mas J.A., Hufnagl P., Ploton D., Trerè D., Rüschoff J. Guidelines of AgNOR quantification - first update. Virchows Arch. 427:1995a;341.
41. Öfner D., Riedman B., Maier H., Hittmair A., Rumer A., Tötsch M., Spechtenhauser B., Böcker W., Schmid K.W. Standardized staining and analysis of argyrophilic nucleolar organizer region associated proteins (AgNORs) in radically resected colorectal adenocarcinoma. Correlation with tumour stage and long-term survival. J. Pathol. 175:1995b;441-448.
42. Ogura S., Abe S., Sukoh N., Kunikane H., Nakajima I., Inoue K., Kawakami Y. Correlation between nucleolar organizer regions visualized by silver staining and the growth rate in lung adenocarcinoma. Cancer. 70:1992;63-68.
43. Orita T., Kajiwara K., Nishizaki T., Ikeda N., Kamizyo T., Aoki H. Nucleolar organizer regions in meningioma. Neurosurgery. 26:1990;43-46.
44. Pich A., Pisani P., Krengli M., Cappello N., Navone R. Argyrophilic nucleolar organizer region counts and prognosis in pharyngeal carcinoma. Br. J. Cancer. 64:1991a;327-332.
45. Pich A., Valente G., Margaria E., Azzoni L., Tasso M., Stramignoni A. Argyrophilic nucleolar organizer region counts and Ki67 scores in human renal cell carcinoma. Pathol. Res. Pract. 187:1991b;482-486.
46. Pich A., Chiusa L., Marmont F., Cappello N., Navone R. Argyrophilic nucleolar organizer region counts in multiple myeloma. A histopathological study on bone marrow trephine biopsies. Virchows Arch. A Pathol. Anat. 421:1992a;143-147.
47. Pich A., Chiusa L., Pisani P., Krengli M., Pia F., Navone R. Argyrophilic nucleolar organizer region counts and proliferating cell nuclear antigen scores are two reliable indicators of survival in pharyngeal carcinoma. J. Cancer Res. Clin. Oncol. 119:1992b;106-110.
48. Pich A., Marmont F., Chiusa L., Cappello N., Resegotti L., Navone R. Argyrophilic nucleolar organizer region counts and prognosis in multiple myeloma. Br. J. Haematol. 82:1992c;681-688.
49. Pich A., Chiarle R., Chiusa L., Palestro G. Argyrophilic nucleolar organizer region counts predict survival in thymoma. Cancer. 74:1994a;1568-1574.
50. Pich A., Chiusa L., Boccadoro M., Marmont F. AgNORs and myeloma prognosis. Leuk. Lymphoma. 12:1994b;383-394.
51. Pich A., Chiusa L., Comino A., Navone R. Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinomas. Virchows Arch. A Pathol. Anat. 424:1994c;143-148.
52. Pich A., Margaria E., Chiusa L. In male breast carcinoma the proliferative activity is a significant prognostic factor. Am. J. Pathol. 145:1994d;481-489.
53. Pich A., Chiarle R., Chiusa L., Ponti R., Geuna M., Casadio C., Maggi G., Palestro G. Long-term survival of thymoma patients by histologic pattern and proliferative activity. Am. J. Surg. Pathol. 19:1995a;918-926.
54. Pich A., Chiusa L., Margaria E. Role of the argyrophilic nucleolar organizer regions (AgNORs) in tumor detection and prognosis. Cancer Detect. Prev. 19:1995b;282-291.
55. Pich A., Margaria E., Chiusa L., Ponti R., Geuna M. DNA ploidy and p53 expression correlate with survival and cell proliferative activity in male breast carcinoma. Human Pathol. 27:1996;676-682.
56. Pich A., Chiarle R., Chiusa L., Motta M., Palestro G. p53 overexpression and thymoma prognosis. Müller-Hermelink H.K., Marx A., Epithelial Tumors of the Thymus: Pathology, Biology, Treatment. 1997a;47-54 Plenum, New York.
57. Pich A., Chiusa L., Cavallo G.P., Margaria E. Prognostic value of AgNORs in tumour pathology. Electron. J. Pathol. Histol. 3:1997b;971-976.
58. Pich A., Chiusa L., Marmont F., Navone R. Risk groups of myeloma patients by histologic pattern and proliferative activity. Am. J. Surg. Pathol. 21:1997c;339-347.
59. Pich A., Margaria E., Chiusa L., Formiconi A. Prognostic value of AgNOR counting. A prospective study in a series of renal cell carcinomas. Oncol. Rep. 4:1997d;749-751.
60. Pich A., Chiusa L., Audisio E., Marmont F. Nucleolar organizer region counts predict complete remission, remission duration and survival in adult myelogenous leukemia patients. J. Clin. Oncol. 16:1998a;1512-1518.
61. Pich A., Margaria E., Chiusa L. Bcl-2 expression in male breast carcinoma. Virchows Arch. 433:1998b;229-235.
62. Ploton D., Menager M., Jeannesson P., Himber G., Pigeon F., Adnet J.J. Improvement in the staining and in the visualisation of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem. J. 18:1986;5-14.
63. Rüschoff J., Bittinger A., Neumann K., Schmitz-Moormann P. Prognostic significance of nucleolar organizing regions (NORs) in carcinomas of the sigmoid colon and rectum. Pathol. Res. Pract. 186:1990a;85-91.
64. Rüschoff J., Neumann K., Contractor H., Plate K., Thomas C. Assessment of nucleolar organizer regions by automatic image analysis in breast cancer: correlation with DNA content, proliferation rate, receptor status and histopathological grading. J. Cancer. Res. Clin. Oncol. 116:1990b;480-485.
65. Schoedel K.E., Martinez A.J., Mahoney T.M., Contis L., Becich M.J. Chordomas: pathological features, ploidy and silver nucleolar organizing region analysis. A study of 36 cases. Acta Neuropathol. 89:1995;139-143.
66. Toikkanen S., Joensuu H. AgNOR counts have no prognostic value in breast cancer. J. Pathol. 169:1993;251-254.
67. Yang A.H., Wang T.Y., Liu H.C. Comparative study of the prognostic value of nuclear grade and silver-binding nucleolar organizer region in renal cell carcinomas. J. Pathol. 166:1992;157-161.
68. Zittoun R., Liso V., Mandelli F., Rotoli V., de Witte T., Gattringer C., Resegotti L., Caronia F., Leoni P., Petti M.C., Solbu G., Vegna M.L., Suciu S. Intensive consolidation chemotherapy versus standard consolidation maintenance in acute myelogenous leukemia (AML) in first remission. An EORTC/GIMEMA phase III trial (AML8 B). The EORTC Leukemia Cooperative Group and the GIMEMA Group. Leukemia. 6:(2):1992;76-77.
69. Zittoun R.A., Mandelli F., Willemze R., et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. New Engl. J. Med. 332:1995;217-223.